The Current Status of Patient Centricity in Medicine Development

Matt Reaney has spent much of his life in and around the healthcare system. He is a son, spouse and parent of remarkably resilient people who live with chronic diseases that involve significant self-management, and he is passionate about helping them use their voices to inform healthcare decisions. It was with this in mind that he embarked on his first role in Patient-Centered care and Patient-focused research more than 20 years ago. He has held positions in pharmaceutical companies, universities, charities, consultancies and hospitals since – sometimes simultaneously – advocating for the patient voice to be heard in intervention design and testing, and in clinical care decision-making. In his role at IQVIA, Matt sets scientific direction for the Patient Centered Solutions team and oversees a variety of qualitative and quantitative research projects and patient-focused communication activities. Alongside this role, Matt maintains a variety of other positions including Expert in Residence at the University of Oxford, Scientific Advisory Council member at Breakthrough T1D, Co-chair of the Study Endpoints Committee at the DIA and Guest Lecturer at the Royal Holloway University of London. He is a Chartered and Practitioner Health Psychologist and a Chartered Scientist. He has a PhD and MSc in Health Psychology and a BSc in Psychology and has been awarded a Fellowship by the Royal Society of Medicine, a Fellowship by the Royal Society of Public Health, and an Associate Fellowship by the British Psychological Society.

Anthony Yanni, MD, is responsible for leading the development and execution of the company’s global patient centricity strategy across all functions of the organization. With a vision to better and more genuinely understand the patient journey in the real-world setting, along with the continued development of a patient-centered corporate culture worldwide, one area in which he is focused is on creating sustainable processes to address key areas that matter to patients and applying their unique insights to the entire product lifecycle – from early research to development and, ultimately, to utilization.Previously, Dr Yanni held multiple roles at Sanofi most recently serving as Head of Patient Insights, Solutions and Outcomes where he led a global team to create a first-in-industry process to integrate the patient and clinician perspective into research portfolio decision-making.Earlier in his career, Dr Yanni spent nearly 15 years in clinical practice serving as a primary care physician, Chief of Internal Medicine and Chief Medical Officer for a health system in the Northeastern United States.Dr Yanni was selected as one of 2021’s 100 Most Inspiring People in the life-sciences industry by PharmaVoice Magazine and most recently was recognized with the Reuters Pharma Europe Patient Champion Award for having “real impact on patients, carers and international health systems”.